Stone Ridge Asset Management’s Utah Medical Products UTMD Stock Holding History

Stone Ridge Asset Management’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,100	Closed	-$227K	–	923
2019 Q4	$227K	Hold	2,100	–	–	0.01%	861
2019 Q3	$201K	Hold	2,100	–	–	0.01%	990
2019 Q2	$201K	Buy	+2,100	New	+$177K	0.01%	1061
2018 Q3	–	Sell	-2,100	Closed	-$231K	–	1311
2018 Q2	$231K	Hold	2,100	–	–	0.01%	1132
2018 Q1	$208K	Buy	+2,100	New	+$187K	0.01%	1210

Other funds holding UTMD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Stone Ridge Asset Management's UTMD Position: Q1 2020 in Review

Stone Ridge Asset Management sold out of Utah Medical Products (UTMD) in Q1 2020, closing a stake of 2,100 shares — an estimated $227K sold.

Stone Ridge Asset Management first reported a position in UTMD in Q1 2018 and held it in 5 quarters. The position peaked at $231K in Q2 2018. 90 funds tracked by Wall St. Rank hold UTMD as of Q1 2020.

Stone Ridge Asset Management reported no remaining Utah Medical Products position as of Q1 2020 after selling out during the quarter.
Stone Ridge Asset Management sold 2,100 Utah Medical Products shares in Q1 2020, an estimated $227K.
Stone Ridge Asset Management first reported a position in Utah Medical Products in Q1 2018 and held it in 5 quarters.
Stone Ridge Asset Management's Utah Medical Products position peaked at $231K in Q2 2018.
90 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2020.

Based on Stone Ridge Asset Management's 13F filing for Q1 2020, filed 5 May 2020.